- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Large Cap High Growth Potential
Indian Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
Torrent Pharmaceuticals
Market Cap: ₹1.1t
Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,168.90
7D
-2.5%
1Y
12.0%
Divi's Laboratories
Market Cap: ₹1.7t
Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.
DIVISLAB
₹6,592.00
7D
-1.1%
1Y
45.8%
Mankind Pharma
Market Cap: ₹944.7b
Develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally.
MANKIND
₹2,288.80
7D
-3.9%
1Y
5.7%